企業プロフィール
Theseus Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- THRX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for THRX.
企業概要
事業概要
Theseus Pharmaceuticals is a precision-oncology company focused on next-generation kinase inhibition and targeted cancer therapy. The company aims to build differentiated assets in genetically defined tumors.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Theseus sits in specialty oncology biotechnology.
ビジネスモデルの特徴
The business depends on clinical proof, target selectivity, and the ability to create a focused oncology franchise.
バイオ業界での位置付け
Theseus is a small-cap oncology catalyst name where early data can materially reshape the story.
今後のカタリスト
- Theseus Pharmaceuticals's catalysts are its kinase-inhibitor programs and any strategy update that clarifies the company's next path forward. The company still needs a clearer development road map.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。